Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema

Otsuka,Hajime; Sugino,Keishi; Hata,Yoshinobu; Makino,Takashi; Koezuka,Satoshi; Isobe,Kazutoshi; Tochigi,Naobumi; Shibuya,Kazutoshi; Homma,Sakae; Iyoda,Akira

doi:10.3892/mco.2016.954

Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema

Authors:
- Hajime Otsuka
- Keishi Sugino
- Yoshinobu Hata
- Takashi Makino
- Satoshi Koezuka
- Kazutoshi Isobe
- Naobumi Tochigi
- Kazutoshi Shibuya
- Sakae Homma
- Akira Iyoda
View Affiliations

Affiliations: Division of Chest Surgery, Toho University School of Medicine, Tokyo 143‑8541, Japan, Division of Respiratory Medicine, Toho University School of Medicine, Tokyo 143‑8541, Japan, Department of Surgical Pathology, Toho University School of Medicine, Tokyo 143‑8541, Japan
Published online on: July 8, 2016 https://doi.org/10.3892/mco.2016.954
Pages: 273-278

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The syndrome of combined pulmonary fibrosis and emphysema (CPFE) has been characterized by severely impaired gas exchange and poor survival. However, the clinical features of patients with lung cancer plus CPFE have remained elusive. The present study performed a retrospective analysis to examine the clinical characteristics and outcome of surgically resected patients with lung cancer plus CPFE. Among 831 patients with primary lung cancer who underwent surgical resection, 23 patients (2.8%) were diagnosed with CPFE and 9 patients (1.1%) with solely idiopathic pulmonary fibrosis (IPF). Thirty‑five patients were stratified as the solely emphysema group with adjustment of the pathological stage. The clinicopathological characteristics of patients in the CPFE group and their outcomes were evaluated and compared with those with the solely IPF or solely emphysema groups. Within the CPFE group, no significant differences in survival between patients with post‑operative acute exacerbation (AE; n=3) and those without AE (n=20) were noted; however, in the solely IPF group, patients with post‑operative AE (n=4) had a significantly shorter survival than those without AE (n=5; P=0.022). The 5‑year survival rate of patients in the CPFE, solely IPF and solely emphysema groups was 22, 22 and 58%, respectively. Furthermore, the CPFE and solely IPF groups showed a significantly shorter survival than the solely emphysema group (P=0.001 and 0.011, respectively). In conclusion, surgically resected lung cancer patients with CPFE had poor survival, which was, in contrast to that of lung cancer patients with solely IPF, not affected by AE.

View Figures

View References

1	Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D and Cordier JF: Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P): Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J. 26:586–593. 2005. View Article : Google Scholar : PubMed/NCBI
2	Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T and Kubo K: Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 15:265–271. 2010. View Article : Google Scholar : PubMed/NCBI
3	Mejía M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C and Selman M: Idiopathic pulmonary fibrosis and emphysema: Decreased survival associated with severe pulmonary arterial hypertension. Chest. 136:10–15. 2009. View Article : Google Scholar : PubMed/NCBI
4	Sugino K, Ishida F, Kikuchi N, Hirota N, Sano G, Sato K, Isobe K, Sakamoto S, Takai Y and Homma S: Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone. Respirology. 19:239–245. 2014. View Article : Google Scholar : PubMed/NCBI
5	Dai H, Liu J, Liang L, Ban C, Jiang J, Liu Y, Ye Q and Wang C: Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respirology. 19:707–713. 2014. View Article : Google Scholar : PubMed/NCBI
6	Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, Fujii Y, Mitsudomi T, Yoshimura M, Maniwa T, et al: Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cance. J Thorac Cardiovasc Surg. 147:1604–1611. 2014. View Article : Google Scholar : PubMed/NCBI
7	Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al: An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
8	Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M and Yamamoto S: CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol. 168:79–83. 1997. View Article : Google Scholar : PubMed/NCBI
9	Single breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique. Statement of the American thoracic society. Am Rev Respir Dis. 136:1299–1307. 1987. View Article : Google Scholar : PubMed/NCBI
10	Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M and Watanabe K: Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 103:1209–1215. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kurashima K, Takayanagi N, Tsuchiya N, Kanauchi T, Ueda M, Hoshi T, Miyahara Y and Sugita Y: The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology. 15:843–848. 2010. View Article : Google Scholar : PubMed/NCBI
12	Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE Jr, Ryu J and Collard HR: Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 144:234–240. 2013. View Article : Google Scholar : PubMed/NCBI
13	Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A, Otsuji M, Yoshida S, Shibuya K, Iizasa T, et al: Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: Analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 126:1141–1146. 2003. View Article : Google Scholar : PubMed/NCBI
14	Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, Dubois RM and Ladas G: Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg. 125:1321–1327. 2003. View Article : Google Scholar : PubMed/NCBI
15	Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, Kawashima T, Kinoshita H, Enomoto Y, Nakajima Y and Shimizu K: Surgical treatment of lung cancer combined with interstitial pneumonia: The effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg. 10:340–346. 2004.PubMed/NCBI
16	Watanabe A, Kawaharada N and Higami T: Postoperative acute exacerbation of IPF after lung resection for primary lung cancer. Pulm Med. 2011:9603162011. View Article : Google Scholar : PubMed/NCBI